aTyr Pharma Inc reports results for the quarter ended in December - Earnings Summary

aTyr Pharma

09/03/2023 22:02

* aTyr Pharma Inc  LIFE.OQ  reported a quarterly adjusted
loss
of 26 cents​​ per share for the quarter ended in December. The
mean expectation of seven analysts for the quarter was for a
loss of 48 cents per share.
    * Revenue was $10.39 million​; analysts expected $214.29
thousand. 
    * aTyr Pharma Inc's reported EPS for the quarter was a loss
of 26
cents​.
    * The mean earnings estimate of analysts had fallen by
about 1.1%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate 
    * aTyr Pharma Inc shares had fallen by 3.0% this quarter.
    * The company reported a quarterly loss of $7.52 million.
    * Wall Street's median 12-month price target for aTyr Pharma
Inc
is $17.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 9 at 10:02 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.48          -0.26          Beat
 Sep. 30 2022      -0.46          -0.46          Met
 Jun. 30 2022      -0.38          -0.44          Missed
 Mar. 31 2022      -0.33          -0.44          Missed